Evolus, Inc. - Common Stock (EOLS)

CUSIP: 30052C107

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+310,726
SEC-reported price per share
$6.94
Number of holders
7
Value change
+$2,157,571
Number of buys
6
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
64,879,792

Security key

30052C107

Report period

Q2 2026

Institutions

7

Top holders

7

Ownership snapshot

Top reported holders of EOLS - Evolus, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Timothy P. Lynch
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: Timothy P. Lynch Showing 1-6 of 15 holder rows.

Quick read

Timothy P. Lynch leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Timothy P. Lynch's linked filing trail.
Comparable ownership Top 5
Timothy P. Lynch 9.9%
Nantahala Capital Management, LLC 8.8%
BlackRock, Inc. 6.9%
PERCEPTIVE ADVISORS LLC 3.8%
Medytox Inc. 3.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Timothy P. Lynch
13D/G
9.9%
$36,305,352
6,425,726 shares
+$7,299,518 31 Dec 2025
Nantahala Capital Management, LLC
13D/G 13F
Company
8.8%
$35,162,902
5,726,857 shares
+$12,129,656 30 Sep 2025
BlackRock, Inc.
13D/G 13F
Company
6.9%
$50,851,038
4,364,896 shares
$0 31 Dec 2024
PERCEPTIVE ADVISORS LLC
13D/G 13F
Company
3.8%
$23,461,512
2,474,843 shares
-$15,682,755 30 Jun 2025
Medytox Inc.
3/4/5 13D/G
Former 10% Owner
3.4%
from 13D/G
$25,359,945
3,381,326 shares
16 Oct 2023
TANG CAPITAL MANAGEMENT LLC
13D/G 13F
Company
1.9%
$7,038,160
1,245,692 shares
-$21,197,145 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
7
Shares
910,946
Rows available
7
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
143
Q2 2026 holders
7
Holder diff
-136
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .